| Stage | ECG | % of rev | PAY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $361M | 100.00% | ECG ×3.41 |
| Gross profit | $183M | 14.85% | $94M | 26.14% | PAY +11.3pp |
| Operating income | $112M | 9.08% | $33M | 9.04% | 0.0pp |
| Pre-tax income | $110M | 8.93% | $36M | 9.88% | PAY +1.0pp |
| Net income | $84M | 6.81% | $26M | 7.09% | PAY +0.3pp |
| Stage | ECG | PAY | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $361M100.00% | ECG ×3.41 |
| Gross profit | 14.85%$183M | 26.14%$94M | PAY +11.3pp |
| Operating income | 9.08%$112M | 9.04%$33M | 0.0pp |
| Pre-tax income | 8.93%$110M | 9.88%$36M | PAY +1.0pp |
| Net income |
| 6.81%$84M |
| 7.09%$26M |
| PAY +0.3pp |
No shared counterparties.